We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$423M
AUM Growth
+$111M
Cap. Flow
+$102M
Cap. Flow %
24.14%
Top 10 Hldgs %
43.89%
Holding
67
New
24
Increased
19
Reduced
4
Closed
19

Top Buys

Rank Stock Value
1
HBI
Hanesbrands
HBI
+$12.8M
2
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
+$12.6M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$11.8M
4
URBN icon
Urban Outfitters
URBN
+$10.1M
5
AEO icon
American Eagle Outfitters
AEO
+$8.96M

Top Sells

Rank Stock Value
1
PAY
Verifone Systems Inc
PAY
+$9.37M
2
PDLI
PDL BioPharma, Inc.
PDLI
+$8.82M
3
PRKS icon
United Parks & Resorts
PRKS
+$7.12M
4
THC icon
Tenet Healthcare
THC
+$5.98M
5
BWLD
Buffalo Wild Wings, Inc.
BWLD
+$5.63M

Sector Composition

Rank Sector Weight
1 Healthcare 35.82%
2 Consumer Discretionary 25.36%
3 Consumer Staples 15.76%
4 Financials 1.88%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$55.9M 13.22%
250,000
+10,000
+4% +$2.18M
ATRS
2
DELISTED
Antares Pharma, Inc.
ATRS
$25.6M 6.06%
11,000,000
-1,300,000
-11% -$2.48M
HAIN icon
3
Hain Celestial
HAIN
$47.8M
$14.8M 3.51%
380,000
+32,000
+9% +$1.2M
FRPT icon
4
Freshpet
FRPT
$2.83B
$14.4M 3.4%
1,416,000
+492,000
+53% +$4.45M
PCRX icon
5
Pacira BioSciences
PCRX
$1.02B
$12.9M 3.06%
400,000
+132,000
+49% +$4.4M
LVS icon
6
Las Vegas Sands
LVS
$30.5B
$12.6M 2.98%
236,000
+94,000
+66% +$5.48M
ARLZ
7
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$12.5M 2.96%
2,836,000
+736,000
+35% +$3.49M
PAY
8
CALL
DELISTED
Verifone Systems Inc
PAY
$12.4M 2.94%
+700,000
New +$11.6M
DECK icon
9
Deckers Outdoor
DECK
$13.3B
$12.4M 2.94%
1,344,000
+624,000
+87% +$6.01M
NVLN
10
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$12M 2.83%
+1,420,000
New +$12.6M
HBI
11
DELISTED
Hanesbrands
HBI
$11.6M 2.74%
+536,000
New +$12.8M
RXDX
12
DELISTED
Ignyta, Inc.
RXDX
$10.6M 2.51%
2,000,000
+536,000
+37% +$3.12M
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$10.5M 2.49%
+650,000
New +$11.8M
SGYP
14
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$10.4M 2.45%
1,700,000
+460,000
+37% +$2.4M
WFM
15
DELISTED
Whole Foods Market Inc
WFM
$9.6M 2.27%
312,000
+112,000
+56% +$3.37M
SGI
16
Somnigroup International
SGI
$15.1B
$9.56M 2.26%
+560,000
New +$8.36M
CPB icon
17
Campbell Soup
CPB
$6.51B
$9.55M 2.26%
+158,000
New +$8.86M
VNDA icon
18
Vanda Pharmaceuticals
VNDA
$312M
$9.25M 2.19%
580,000
+30,000
+5% +$482K
ADMS
19
DELISTED
Adamas Pharmaceuticals
ADMS
$9.06M 2.14%
+536,000
New +$8.29M
NOMD icon
20
Nomad Foods
NOMD
$1.64B
$8.61M 2.04%
900,000
+260,000
+41% +$2.84M
AVDL
21
DELISTED
Avadel Pharmaceuticals
AVDL
$8.6M 2.04%
828,000
+228,000
+38% +$2.51M
URBN icon
22
Urban Outfitters
URBN
$5.99B
$8.54M 2.02%
+300,000
New +$10.1M
ACOR
23
DELISTED
Acorda Therapeutics
ACOR
$8.05M 1.9%
3,567
-1,000
-22% -$2.38M
AEO icon
24
American Eagle Outfitters
AEO
$2.85B
$7.95M 1.88%
+524,000
New +$8.96M
AET
25
DELISTED
Aetna Inc
AET
$7.94M 1.88%
+64,000
New +$7.66M
1
2 3

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Armistice Capital held 67 positions worth $423M, up 36% from $312M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Armistice Capital deployed $102M of net new capital in Q4 2016, opening 24 new positions and adding to 19 existing holdings. Its largest new stake was Hanesbrands: 536,000 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Kate Spade & Company, an estimated $3.28M trimmed.

  • Armistice Capital's largest Q4 2016 buy was Hanesbrands: 536,000 shares worth $11.6M.
  • Armistice Capital added most to Deckers Outdoor in Q4 2016, an estimated $6.01M increase.
  • Armistice Capital's biggest Q4 2016 reduction was Kate Spade & Company, cutting an estimated $3.28M.
  • Armistice Capital fully exited Verifone Systems Inc in Q4 2016, selling an estimated $9.37M.
  • Armistice Capital's ten largest holdings make up 44% of its $423M portfolio in Q4 2016.
  • Armistice Capital opened 24 new positions and closed 19 in Q4 2016.
  • Armistice Capital's portfolio value rose 36% quarter-over-quarter to $423M.

Based on Armistice Capital's 13F filing for Q4 2016, filed 15 Feb 2017.